Dupimulab reduced exacerbations and improved lung functions in patients with moderate-to-severe asthma and prior exacerbations: Liberty Asthma Traverse study

Corren, J; Castro, M; Maspero, JF; Humbert, M; Halpin, DMG; Altincatal, A; Pandit-Abid, N; Soler, X; Siddiqui, S; Jacob-Nara, JA; Deniz, Y; Rowe, PJ

Dupimulab reduced exacerbations and improved lung functions in patients with moderate-to-severe asthma and prior exacerbations: Liberty Asthma Traverse study

https://hdl.handle.net/10871/133478
Open external identifier URL

journal contribution

posted on 2025-08-01, 17:05 authored by J Corren, M Castro, JF Maspero, M Humbert, DMG Halpin, A Altincatal, N Pandit-Abid, X Soler, S Siddiqui, JA Jacob-Nara, Y Deniz, PJ Rowe

No description available

Funding

Sanofi and Regeneron Pharmaceuticals, Inc.

History

Related Materials

1.
EISSN - Is published in https://portal.issn.org/resource/ISSN/1931-3543
2.
ISSN - Is published in https://portal.issn.org/resource/ISSN/0012-3692

Rights

External DOI

https://doi.org/10.1016/j.chest.2022.08.1603

Journal

Chest Journal

Pagination

a1936-a1938

Publisher

Elsevier

Version

Accepted Manuscript

Language

en

FCD date

2023-06-22T12:50:26Z

FOA date

2023-09-30T23:00:00Z

Citation

Vol. 162, No. 4, pp. a1936-a1938

Department

Clinical and Biomedical Sciences

Usage metrics

Keywords

No keyword

Dupimulab reduced exacerbations and improved lung functions in patients with moderate-to-severe asthma and prior exacerbations: Liberty Asthma Traverse study

Funding

Sanofi and Regeneron Pharmaceuticals, Inc.

History

Related Materials

Rights

External DOI

Journal

Pagination

Publisher

Version

Language

FCD date

FOA date

Citation

Department

Usage metrics

Categories

Keywords

Licence

Exports